A brief Overview of a Fatal Disease Namely Cancer
In today's era, cancer is a dangerous and terrible disease which cause due to rapid increment of unusual cells within the body. Cancer is the second influential cause of death in the world. It has become very difficult overcome cancerous disease. About an average of 10 million people died per year from cancer. The major cause of cancer is sudden change in DNA within the cells. As a result normal cells convert into cancerous cells which enhance the process of metastasis. There are some treatments of this dangerous disease but those are so expensive not everyone can afford it easily. So, it’s our responsibility to spread awareness among the people about this disease. The purpose of this article is providing awareness about this deadly disease, and to follow routine activities so that the occurrence of this disease could be avoided.
2. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, et al. (November 2007). “The genomic landscapes of human breast and colorectal cancers”. Science. 318 (5853): 1108-13.
3. Moses AWG, Slater C, Preton T, Barber MD, Fearon KCH. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and Br J Cancer 2004; 90: 996-1002.
4. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer centre and the implications for oncology. J Clin Oncol 2000; 18(13):2505-2514.
5. Deway WC, Ling CC, Meyn RE. Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys. 1995; 33:781-796.
6. Jenkins S (1978) Diagnostic delay in the neoplastic disease. J R Coll Gen Pract 28:724-728.
7. Sandler DP Epidermiology and etiology of acute lukemia: an update. Lukemia 6 (Suppl 4):3-5 (1992).
8. Theriault G. Electromagnetic fields and cancer risks. Rev Epidem et Sante Pulb 40:S55-S62 (1992).
9. Leventhal BG, Donaldson SS. Hodgkin’s disease. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 2ed. Philadelphia: Lippincott, 1993: 577-94.
10. Deane K, Carman M, Fitch M. The cancer journey: bridging art therapy and museum education. Can Oncol Nurs J 2000, 10 (4):140-142.
11. Predeger E. Womanspirit: a journey into healing through art in breast cancer. Adv Nurs Sci 1996; 18 (3):150-156.
12. Antonovsky A, Hartman H (1974) Delay in the detection of cancer: a review of the literature. Health Educ Monogr 2:98-128.
13. Duncan RE,Evans AT. Diagnosis of primary retroperitoneal tumors. J Urol 1977;11 : 19-23.
14. Van Dan PA, Lowe DG, McKenzie-Gray B, Shepherd JH. Retroperitoneal soft tissue sarcomas: a review of the literature. Obstet Gynecol Surv 1990;45:670-682.
15. Verheij M. Clinical biomarkers and imaging for radiotherapy-induced cell death. Cancer Metastatis Rev. 2008; 27: 471-480.
16. Cragg MS, Harris C, Strasser, Scott CL. Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics. Nat Rev Cancer. 2009; 9: 321-326.
17. Trauger-Querry B, Haghighi KR. Balancing the focus: art and music therapy for pain control and symptom management in hospice care. Hosp J-Phys Psychosoc Pastor Care Dying 1999; 14 (1):25-38.
18. Appleton VE. An art therapy protocol for the medical trauma setting. Art Ther: J Am Art Ther Assoc 1993;10 (2):71-77.
19. Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Buchler MW, Friess H, Martignoni ME. Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 2008; 12: 1193- 201.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.